Life Scientist > Biotechnology

Reduced need for blood transfusions in thalassemia patients

15 May, 2020

A new medication is reducing the need for blood transfusions in thalassemia patients and improving bone-marrow transplant outcomes.


Microrobotic needle screwed into cancer tissue

14 May, 2020

Scientists have developed a drug-loaded microrobotic needle that effectively targets and remains attached to cancerous tissue in lab experiments.


Drug trial to make COVID-19 patients less infectious

13 May, 2020

The drug interferon could stop outbreaks of COVID-19 by reducing the infectiousness of people who contract the SARS-Cov-2 virus.


AI helps optimise drug therapies for infectious diseases

01 May, 2020

Researchers are harnessing the power of artificial intelligence in an attempt to dramatically accelerate the discovery of drug combination therapies.


Microneedle array for vaccine delivery developed

24 April, 2020

The new vaccine delivery system contains 400 tiny needles, each just 0.5 mm in length and made from sugar and the specific cargo being delivered.


New influenza treatment found to reduce spread of virus

21 April, 2020

A new antiviral drug for influenza can treat the infection at the same time as reducing the risk of transmission to others.


UQ continues testing for COVID-19 vaccine, treatment

20 April, 2020

UQ's potential COVID-19 vaccine enters a new phase, and over 10,000 compounds have been tested to identify drug candidates that may help treat the disease.


New melanoma treatment triggers cell death

14 April, 2020

Using drugs to inhibit two separate proteins, researchers found that they could effectively kill melanoma cells by inducing apoptosis.


Bacteria engineered to protect bees from colony collapse

01 April, 2020

Scientists engineered bacteria to live in the guts of honey bees and act as biological factories, pumping out medicines protecting the bees against both Varroa mites and deformed wing virus.


Potential drug target, inhibitor identified for SARS-CoV-2

16 March, 2020

Two new studies out of the US show promise for the treatment of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).


Sartorius BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform

11 March, 2020

Engineered to address the rigorous requirements and complexity of biologics manufacture, Sartorius's BIOSTAT STR Generation 3 bioreactor is a robust industrial platform consisting of hardware, software and consumables for single-use process development and commercial biomanufacturing.


FDA approves new drug for Duchenne muscular dystrophy

05 March, 2020

A clinical trial of the drug, known as VYONDYS 53 (golodirsen), established that it was well tolerated and acted to restore dystrophin protein.


Queensland and India form bioscience alliance

04 March, 2020

Life Sciences Queensland (LSQ) has formed a partnership with India's Association of Biotechnology Led Enterprises (ABLE).


DuPont DELRIN SC698 resin for medical devices

11 February, 2020

The DELRIN SC698 resin with integrated lubrication can help improve patient comfort and ease of use by ensuring smooth actuation of high-load drug delivery devices like inhalers, injectors and pumps.


New drug combination destroys deadly bacterial infection

30 January, 2020

The treatment has been found to completely kill a bacterial infection that can be deadly to patients with cystic fibrosis and other chronic lung conditions such as bronchiectasis.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd